美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
63629-9863-1	63629-9863	HUMAN PRESCRIPTION DRUG	Cevimeline Hydrochloride	Cevimeline Hydrochloride	CAPSULE	ORAL	20231130	N/A	ANDA	ANDA203775	Bryant Ranch Prepack	CEVIMELINE HYDROCHLORIDE	30 mg/1	30 CAPSULE in 1 BOTTLE (63629-9863-1)
63629-9863-2	63629-9863	HUMAN PRESCRIPTION DRUG	Cevimeline Hydrochloride	Cevimeline Hydrochloride	CAPSULE	ORAL	20240905	N/A	ANDA	ANDA203775	Bryant Ranch Prepack	CEVIMELINE HYDROCHLORIDE	30 mg/1	60 CAPSULE in 1 BOTTLE (63629-9863-2)
63629-9863-3	63629-9863	HUMAN PRESCRIPTION DRUG	Cevimeline Hydrochloride	Cevimeline Hydrochloride	CAPSULE	ORAL	20240905	N/A	ANDA	ANDA203775	Bryant Ranch Prepack	CEVIMELINE HYDROCHLORIDE	30 mg/1	90 CAPSULE in 1 BOTTLE (63629-9863-3)
16571-657-10	16571-657	HUMAN PRESCRIPTION DRUG	Cevimeline Hydrochloride	Cevimeline Hydrochloride	CAPSULE	ORAL	20140617	N/A	ANDA	ANDA203775	Rising Pharma Holdings, Inc.	CEVIMELINE HYDROCHLORIDE	30 mg/1	100 CAPSULE in 1 BOTTLE (16571-657-10)
87063-180-01	87063-180	HUMAN PRESCRIPTION DRUG	Cevimeline Hydrochloride	Cevimeline Hydrochloride	CAPSULE	ORAL	20260518	N/A	ANDA	ANDA203775	ASCLEMED USA INC.	CEVIMELINE HYDROCHLORIDE	30 mg/1	100 CAPSULE in 1 BOTTLE (87063-180-01)
87063-180-30	87063-180	HUMAN PRESCRIPTION DRUG	Cevimeline Hydrochloride	Cevimeline Hydrochloride	CAPSULE	ORAL	20260518	N/A	ANDA	ANDA203775	ASCLEMED USA INC.	CEVIMELINE HYDROCHLORIDE	30 mg/1	30 CAPSULE in 1 BOTTLE (87063-180-30)
87063-180-60	87063-180	HUMAN PRESCRIPTION DRUG	Cevimeline Hydrochloride	Cevimeline Hydrochloride	CAPSULE	ORAL	20260518	N/A	ANDA	ANDA203775	ASCLEMED USA INC.	CEVIMELINE HYDROCHLORIDE	30 mg/1	60 CAPSULE in 1 BOTTLE (87063-180-60)
87063-180-90	87063-180	HUMAN PRESCRIPTION DRUG	Cevimeline Hydrochloride	Cevimeline Hydrochloride	CAPSULE	ORAL	20260518	N/A	ANDA	ANDA203775	ASCLEMED USA INC.	CEVIMELINE HYDROCHLORIDE	30 mg/1	90 CAPSULE in 1 BOTTLE (87063-180-90)